Cambridge, United Kingdom

Suzanne J Gibson

This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Medimmune Limited. Active years: 2020-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suzanne J Gibson. Retrieved from https://idiyas.com/inventor/suzanne-j-gibson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Suzanne J Gibson: Innovator in Mammalian Promoter Design

Introduction

Suzanne J Gibson is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of molecular biology, particularly in the design of mammalian promoters. With a total of 2 patents, her work has advanced our understanding of transcriptional dynamics in mammalian cells.

Latest Patents

One of her latest patents is focused on the in silico design of mammalian promoters with user-defined functionality. This innovative approach allows for the construction of mammalian promoters based on simple design rules, even when composite transcription factor binding sites do not function synergistically. By analyzing host-cell transcriptional machinery components in silico, she identified transcription factors that exhibit desired expression dynamics. The research demonstrated that when elements are specifically selected to prevent combinatorial interactions, heterotypic promoter activities can be accurately modeled based on binding site copy numbers. This work led to the creation of CHO cell promoters that exhibited designed activity levels and long-term expression stability in vitro.

Another significant patent addresses the prevention of N-terminal truncation in IgG light chains. Gibson discovered that recombinant antibody light chains with a murine secretory leader sequence and an SYE motif at the N-terminus are prone to truncation during post-translational processing. Her findings provide two effective protein engineering solutions: altering the SYE amino acid sequence or changing the secretory leader peptide sequence. Both solutions have proven effective in preventing N-terminal light chain truncation.

Career Highlights

Gibson's career is marked by her innovative research and contributions to the field of biotechnology. She is currently associated with Medimmune Limited, where she continues to push the boundaries of scientific understanding and application in her area of expertise.

Collaborations

Throughout her career, Gibson has collaborated with notable colleagues, including Diane Hatton and Daniel Ramsay Higazi. These collaborations have further enriched her research and contributed to the advancement of her projects.

Conclusion

Suzanne J Gibson is a trailblazer in the field of molecular biology, with her patents reflecting her innovative spirit and dedication to scientific advancement. Her work in mammalian promoter design and antibody engineering continues to have a lasting impact on biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…